Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VINCRISTINE Cause Therapy partial responder? 707 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 707 reports of Therapy partial responder have been filed in association with VINCRISTINE (VinCRIStine Sulfate). This represents 1.0% of all adverse event reports for VINCRISTINE.

707
Reports of Therapy partial responder with VINCRISTINE
1.0%
of all VINCRISTINE reports
145
Deaths
100
Hospitalizations

How Dangerous Is Therapy partial responder From VINCRISTINE?

Of the 707 reports, 145 (20.5%) resulted in death, 100 (14.1%) required hospitalization, and 40 (5.7%) were considered life-threatening.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VINCRISTINE. However, 707 reports have been filed with the FAERS database.

What Other Side Effects Does VINCRISTINE Cause?

Febrile neutropenia (8,676) Off label use (6,562) Disease progression (5,252) Neutropenia (4,982) Drug ineffective (4,084) Pyrexia (3,460) Product use in unapproved indication (3,073) Thrombocytopenia (2,940) Sepsis (2,791) Anaemia (2,603)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) ETOPOSIDE (670) BEVACIZUMAB (632)

Which VINCRISTINE Alternatives Have Lower Therapy partial responder Risk?

VINCRISTINE vs VINDESINE VINCRISTINE vs VINORELBINE VINCRISTINE vs VINORELBINE\VINORELBINE VINCRISTINE vs VIREAD VINCRISTINE vs VISIPAQUE

Related Pages

VINCRISTINE Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder VINCRISTINE Demographics